btg
BTG INTERNATIONAL INC.
Süreç
- Başvuru 31 Mart 2016
- Bültende yayın Resmî Marka Bülteni 266 · 12 Aralık 2016
- İtiraz penceresi (2 ay) Son gün 12 Şubat 2017 · kapandı
- Tescil Tescil no 2016 77018· Gazete 455 (28 Eylül 2018)
- Yenileme Koruma süresi Mart 2026 itibarıyla dolmuş görünüyor. Yenilendiyse TÜRKPATENT kaydında görünür; bu sayfa yenilemeleri izleyemez.
Resmî süreler ve işlemler için TÜRKPATENT esastır; Nomist bilgilendirme aracıdır.
Sınıflar ve kapsam
Mal ve hizmet listesi
Pharmaceutical and medicinal preparations and substances; veterinary preparations and substances; sanitary preparations for medical purposes; dietetic substances adapted for medical use, vaccines; sera; diagnostic reagents and substances, all for in vivo use; antibodies, therapeutic antibodies for use as anti-lymphocytic agents; pharmaceutical preparations in the form of foams or for use in producing foams; pharmaceutical preparations in the form of foams or for use in producing foams, for sclerotherapy, phlebology, angiology or proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; chemical reagents for medical or veterinary purposes; chemical reagents for therapeutic and diagnostic purposes; chemico-pharmaceutical preparations; chemical preparations for medical or pharmaceutical purposes; pharmaceutical preparations for the treatment of cancer; pharmaceutical and veterinary preparations for the reduction or elimination of circulating cytokines; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of multiple neurodegeneration and multiple sclerosis; pharmaceutical preparations for the treatment of Alzheimer's disease; pharmaceutical preparations for the treatment of methotrexate toxicity; pharmaceutical preparations for the treatment of immune disorders including type 1 diabetes, psoriasis, coeliac disease and rheumatoid arthritis; pharmaceutical preparations for the treatment of cancer including prostate, oesophageal and brain cancer and leukaemias; pharmaceutical preparations for the treatment of sepsis; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolization; pharmaceutical preparations and substances for embolization of tumours and arteriovenous malformations (AVMs); pharmaceutical prepraations and substances for use in the circulatory system for the treatment of tumours and arteriovenous malformations (AVMs); adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical or veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemical preparations for medical or pharmaceutical purposes for the treatment of envenomation by snakes; medicines for the treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of pre- eclampsia; chemical reagents for medical or veterinary therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia; chemical preparations for medical or pharmaceutical purposes and medicines for use in the treatment of digoxin, digitalis or other cardio -active glycoside toxicity and for use in the treatment of pre- eclampsia; tran sarterial chemoembolization pharmaceutical preparations, vaccines and sera; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances for medical purposes; radiopharmaceuticals; therapeutic agents for delivery of radioactive material to target sites within the body; beads, including microscopic radioactive be … (liste kısaltıldı; tamamı TÜRKPATENT kaydında)
Aynı bültende benzer başvurular
Bülten 266 içindeki 933 aynı-sınıf başvuru arasında Nomist'in benzerlik algoritmasına takılan yok.